Article History
Accepted: 8 August 2022
First Online: 27 August 2022
Declarations
:
: SRG has consulted for Janssen Pharmaceuticals, Sanofi-Genzyme, Wugen Inc., and Oncovalent Theapeutics, and received travel funding from Adaptive Biosciences. SS and FC declare no conflicts of interest.
: This article does not contain any studies with human or animal subjects.